CD8+ T lymphocytes are widely acknowledged as pivotal mediators of effective anti-tumor immunity, with their infiltrating density and functional competence within the TME being critical determinants of the potency of the host anti-tumor response (22–24). This evidence concerns the gene CD8A and neoplasm.